Roles of the gut in glucose homeostasis

Diabetes Care

Volumn 39, Issue 6, 2016, Pages 884-892

  Holst, Jens Juul ^a   Gribble, Fiona ^b   Horowitz, Michael ^c   Rayner, Chris K ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INCRETIN; GLUCOSE;

ARTICLE; DOWN REGULATION; ENDOCRINE FUNCTION; GLUCOSE HOMEOSTASIS; GLUCOSE INTAKE; HORMONE RESPONSE; HUMAN; INCRETIN EFFECT; INSULIN RELEASE; INTESTINE; INTESTINE FLORA; INTESTINE MOTILITY; LIVER METABOLISM; METABOLIC REGULATION; NONHUMAN; STEADY STATE; STOMACH ABSORPTION; STOMACH EMPTYING; DIGESTION; EATING; GASTROINTESTINAL TRACT; HOMEOSTASIS; HYPERGLYCEMIA; INTESTINE ABSORPTION; LIVER; MALE; METABOLISM; NERVOUS SYSTEM FUNCTION; PHYSIOLOGY; POSTPRANDIAL STATE; STOMACH;

DIGESTION; EATING; GASTRIC EMPTYING; GASTROINTESTINAL TRACT; GLUCOSE; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; INCRETINS; INTESTINAL ABSORPTION; LIVER; MALE; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; POSTPRANDIAL PERIOD; STOMACH;

EID: 84971267221     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0351     Document Type: Article

References (83)

1. Madsbad S, Kehlet H, Hilsted J, Tronier B. Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose. Diabetes 1983;32:436-438
2. Perley MJ, Kipnis DM. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest 1967;46:1954-1962
3. McIntyre N, Holdsworth CD, Turner DS. New interpretation of oral glucose tolerance. Lancet 1964;2:20-21
4. Nauck MA, Homberger E, Siegel EG, et al. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 1986;63: 492-498
5. Bagger JI, Knop FK, Lund A, Vestergaard H, Holst JJ, Vilsbøll T. Impaired regulation of the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab 2011;96:737-745
6. Hare KJ, Vilsbøll T, Holst JJ, Knop FK. Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2010;298: E832-E837
7. Lindgren O, Carr RD, Deacon CF, et al. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans. J Clin Endocrinol Metab 2011;96:2519-2524
8. Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res 2004;36:747-754
9. Nauck M, Stöckmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulindependent) diabetes. Diabetologia 1986;29: 46-52
10. Alfa RW, Park S, Skelly KR, et al. Suppression of insulin production and secretion by a decretin hormone. Cell Metab 2015;21:323-333
11. Stenquist B, Knutson U, Olbe L. Gastric acid responses to adequate and modified sham feeding and to insulin hypoglycemia in duodenal ulcer patients. Scand J Gastroenterol 1978;13: 357-362
12. Schwartz TW, Stenquist B, Olbe L. Cephalic phase of pancreatic-polypeptide secretion studied by sham feeding in man. Scand J Gastroenterol 1979;14:313-320
13. Veedfald S, Plamboeck A, Deacon CF, et al. Cephalic phase secretion of insulin and other enteropancreatic hormones in humans. Am J Physiol Gastrointest Liver Physiol 2016;310: G43-G51
14. Holst JJ, Schwartz TW, Knuhtsen S, Jensen SL, Nielsen OV. Autonomic nervous control of the endocrine secretion from the isolated, perfused pig pancreas. J Auton Nerv Syst 1986;17: 71-84
15. Hansen L, Lampert S, Mineo H, Holst JJ. Neural regulation of glucagon-like peptide-1 secretion in pigs. Am J Physiol Endocrinol Metab 2004;287:E939-E947
16. Horowitz M, Dent J, Fraser R, Sun W, Hebbard G. Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci 1994; 39(Suppl.):7S-13S
17. Jones KL, O'Donovan D, Russo A, et al. Effects of drink volume and glucose load on gastric emptying and postprandial blood pressure in healthy older subjects. Am J Physiol Gastrointest Liver Physiol 2005;289:G240-G248
18. Brener W, Hendrix TR, McHugh PR. Regulation of the gastric emptying of glucose. Gastroenterology 1983;85:76-82
19. Horowitz M, Edelbroek MA, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993;36:857-862
20. Jones KL, Horowitz M, Carney BI, Wishart JM, Guha S, Green L. Gastric emptying in early noninsulin-dependent diabetes mellitus. J Nucl Med 1996;37:1643-1648
21. Jacobsen SH, Bojsen-Møller KN, Dirksen C, et al. Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals. Diabetologia 2013;56:2250-2254
22. Ma J, Pilichiewicz AN, Feinle-Bisset C, et al. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes. Diabet Med 2012;29:604-608
23. Lentle RG, Janssen PW. Manipulating digestion with foods designed to change the physical characteristics of digesta. Crit Rev Food Sci Nutr 2010;50:130-145
24. Horowitz M, Jones K, Edelbroek MA, Smout AJ, Read NW. The effect of posture on gastric emptying and intragastric distribution of oil and aqueous meal components and appetite. Gastroenterology 1993;105:382-390
25. Bohl M, Bjørnshave A, Rasmussen KV, et al. Dairy proteins, dairy lipids, and postprandial lipemia in persons with abdominal obesity (DairyHealth): a 12-wk, randomized, parallelcontrolled, double-blinded, diet intervention study. Am J Clin Nutr 2015;101:870-878
26. Little TJ, Doran S, Meyer JH, et al. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab 2006;291:E647-E655
27. Allescher HD, Daniel EE, Dent J, Fox JE, Kostolanska F. Neural reflex of the canine pylorus to intraduodenal acid infusion. Gastroenterology 1989;96:18-28
28. Levin F, Edholm T, Schmidt PT, et al. Ghrelin stimulates gastric emptying and hunger in normalweight humans. J Clin Endocrinol Metab 2006;91: 3296-3302
29. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 1993;38:665-673
30. Gray GM, Ingelfinger FJ. Intestinal absorption of sucrose in man: interrelation of hydrolysis and monosaccharide product absorption. J Clin Invest 1966;45:388-398
31. Wong JM, Jenkins DJ. Carbohydrate digestibility and metabolic effects. J Nutr 2007; 137(Suppl.):2539S-2546S
32. Puertollano E, Kolida S, Yaqoob P. Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr Opin Clin Nutr Metab Care 2014;17:139-144
33. Troy S, Soty M, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008;8: 201-211
34. Saeidi N, Meoli L, Nestoridi E, et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 2013;341:406-410
35. Bantle AE, Wang Q, Bantle JP. Post-gastric bypass hyperinsulinemic hypoglycemia: fructose is a carbohydrate which can be safely consumed. J Clin Endocrinol Metab 2015;100: 3097-3102
36. Kellett GL. The facilitated component of intestinal glucose absorption. J Physiol 2001;531: 585-595
37. Thazhath SS, Marathe CS, Wu T, et al. The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial. Diabetes 2016;65: 269-275
38. Rhee NA, Wahlgren CD, Pedersen J, et al. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of smallintestinal enteroendocrine cells in obese patients with type 2 diabetes. Diabetologia 2015; 58:2254-2258
39. Nguyen NQ, Debreceni TL, Bambrick JE, et al. Rapid gastric and intestinal transit is a major determinant of changes in blood glucose, intestinal hormones, glucose absorption and postprandial symptoms after gastric bypass. Obesity (Silver Spring) 2014;22:2003-2009
40. Dirksen C, Jørgensen NB, Bojsen-Møller KN, et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes 2013;37:1452-1459
41. Berg P, McCallum R. Dumping syndrome: a review of the current concepts of pathophysiology, diagnosis, and treatment. Dig Dis Sci 2016; 61:11-18
42. Trahair LG, Horowitz M, Hausken T, Feinle-Bisset C, Rayner CK, Jones KL. Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, mesenteric blood flow, and glycemic responses to intraduodenal glucose in healthy older subjects. J Clin Endocrinol Metab 2014; 99:E2628-E2634
43. Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007;92:4678-4685
44. Ramnanan CJ, Edgerton DS, Cherrington AD. Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production. Cell Metab 2012;15:656-664
45. Schwartz MW, Seeley RJ, Tschöp MH, et al. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 2013;503: 59-66
46. Patti ME, McMahon G, Mun EC, et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005;48:2236-2240
47. Jørgensen NB, Jacobsen SH, Dirksen C, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab 2012;303: E122-E131
48. Niijima A. Neural mechanisms in the control of blood glucose concentration. J Nutr 1989; 119:833-840
49. Hölzer HH, Turkelson CM, Solomon TE, Raybould HE. Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive afferent pathway in rats. Am J Physiol 1994;267: G625-G629
50. Kronborg O. Clinical results 6 to 8 years after truncal vagotomy and drainage for duodenal ulcer in 500 patients. Acta Chir Scand 1975;141: 657-663
51. Plamboeck A, Veedfald S, Deacon CF, et al. Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty. Eur J Endocrinol 2013;169:187-201
52. Seoane-Collazo P, Fernø J, Gonzalez F, et al. Hypothalamic-autonomic control of energy homeostasis. Endocrine 2015;50:276-291
53. Duca FA, Bauer PV, Hamr SC, Lam TK. Glucoregulatory relevance of small intestinal nutrient sensing in physiology, bariatric surgery, and pharmacology. Cell Metab 2015;22:367-380
54. Rasmussen BA, Breen DM, Luo P, et al. Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats. Gastroenterology 2012;142:834-843
55. Rasmussen BA, Breen DM, Duca FA, et al. Jejunal leptin-PI3K signaling lowers glucose production. Cell Metab 2014;19:155-161
56. Baum F, Nauck MA, Ebert R, et al. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist. Digestion 1992;53:189-199
57. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007;117: 13-23
58. Grill HJ, Hayes MR. Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metab 2012;16:296-309
59. Sjölund K, Sandén G, Håkanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983;85: 1120-1130
60. Gribble FM, Reimann F. Enteroendocrine cells: chemosensors in the intestinal epithelium. Annu Rev Physiol 2016;78:277-299
61. Miholic J, Orskov C, Holst JJ, Kotzerke J, Meyer HJ. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci 1991;36:1361-1370
62. Schirra J, Katschinski M, Weidmann C, et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 1996;97:92-103
63. Færch K, Torekov SS, Vistisen D, et al. GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study. Diabetes 2015;64:2513-2525
64. Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011;54:10-18
65. Nguyen NQ, Debreceni TL, Bambrick JE, et al. Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia. J Clin Endocrinol Metab 2015;100:968-976
66. Gribble FM, Williams L, Simpson AK, Reimann F. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 2003; 52:1147-1154
67. Christensen LW, Kuhre RE, Janus C, Svendsen B, Holst JJ. Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine. Physiol Rep 2015;3:3
68. Jang HJ, Kokrashvili Z, Theodorakis MJ, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci U S A 2007; 104:15069-15074
69. Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann F. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 2009;52:289-298
70. Tolhurst G, Reimann F, Gribble FM. Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol 2009;587:27-32
71. Maersk M, Belza A, Holst JJ, et al. Satiety scores and satiety hormone response after sucrose-sweetened soft drink compared with isocaloric semi-skimmed milk and with noncaloric soft drink: a controlled trial. Eur J Clin Nutr 2012;66:523-529
72. Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3:153-165
73. Lund A, Vilsbøll T, Bagger JI, Holst JJ, Knop FK. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes. Am J Physiol Endocrinol Metab 2011;300:E1038-E1046
74. Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ. Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism 1994;43: 104-108
75. Richards P, Parker HE, Adriaenssens AE, et al. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes 2014;63:1224-1233
76. de Heer J, Rasmussen C, Coy DH, Holst JJ. Glucagon-like peptide-1, but not glucosedependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 2008;51:2263-2270
77. Jørgensen NB, Dirksen C, Bojsen-Møller KN, et al. Exaggerated glucagon-like peptide 1 response is important for improved b-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes 2013;62:3044-3052
78. Salehi M, Gastaldelli A, D'Alessio DA. Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. Gastroenterology 2014;146:669-680
79. McLaughlin T, Peck M, Holst J, Deacon C. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered utrient delivery. J Clin Endocrinol Metab 2010;95:1851-1855
80. Wu H, Tremaroli V, Bäckhed F. Linking microbiota to human diseases: a systems biology perspective. Trends Endocrinol Metab 2015;26: 758-770
81. Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 2015;22:228-238
82. Mikkelsen KH, Frost M, Bahl MI, et al. Effect of antibiotics on gut microbiota, gut hormones and glucose metabolism. PLoS One 2015;10: e0142352
83. Vrieze A, Out C, Fuentes S, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol 2014;60:824-831